Yes, still think there are good signs of brilacidin being a safe and effective anti-inflammatory drug for both oral and GI mucosa. For sure it shows good antibiotic application given IV for skin infections. I'm pretty sure those same properties would translate to a safe and effective topical antibiotic/anti-inflammatory as well.
Hah, I wish I was an "experienced" investor. Learning to be more skeptical, objective, and realistic, and still have a ways to go on learning when to sell. It's all speculation, and of course very hard to predict the future.
Hoping that a BP sees the same promise we see and provides some capital for us to develop brilacidin, and soon. Odds of that are pretty good, and will give us a big boost if/when it happens.